Device Trial Radar · NCT05481359
AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Apr 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Sep 12, 2022
Primary completion
Oct 27, 2022
Study completion Nov 17, 2023
Sponsor
- Lead sponsor
- Ablacon, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Cortex
- First posted
- Aug 1, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This post-market global registry will evaluate the ability of Electrographic Flow (EGF™) mapping to identify atrial fibrillation (AF) sources and guide ablation therapy in patients with atrial fibrillation in real-world setting.
Conditions
- Atrial Fibrillation, Persistent
- Atrial Fibrillation
- Arrhythmias, Cardiac
- Heart Diseases
Interventions
Electrographic Flow™ (EGF) mapping and ablationDevice
Electrographic Flow™ (EGF) mapping enables the full spatiotemporal reconstruction of organized atrial electrical wavefront propagation to identify active sources or origins of excitation that may trigger atrial fibrillation (AF). EGF mapping involves 1 minute recordings of unipolar electrograms from a basket catheter, which are then processed with the EGF algorithm (Ablamap® Software). Several basket catheter positions are acquired in standard positions in both the left and right atria. EGF-identified sources with activity levels exceeding the recommended threshold are deemed significant and are targeted for ablation. The success of the ablation is confirmed through an EGF remap, where elimination of the source is defined as reduction of EGF source activity below the threshold.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Acute Procedure SuccessTime frame: During the procedure
Locations
5 sites in 3 countries. Site status is shown where the registry gives one.
Piedmont Healthcare
Athens, Georgia
Piedmont Atlanta Hospital
Atlanta, Georgia
Mount Sinai Hospital
New York, New York
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.